Literature DB >> 26742511

Asthma COPD Overlap Syndrome on CT Densitometry: A Distinct Phenotype from COPD.

Yanli Gao1, Xiaoli Zhai1, Kun Li1, Hong Zhang2, Ying Wang2, Yong Lu2, Zhenyu Pan1, Lei Zhang1, Kewu Huang2, Renyou Zhai1.   

Abstract

Patients with asthma COPD overlap syndrome (ACOS) are an important but poorly characterized group. This study sought to explore the distinct characteristics of ACOS on CT densitometry. The study population was randomly selected from communities via questionnaires. All participants underwent low-dose volumetric chest CT both before and after bronchodilator administration. Each CT scan was performed at full-inspiration and full-expiration for CT densitometry. Emphysema index (EI), air trapping (AT), mean lung density (MLD) and total lung volume (TLV) were measured and compared between the ACOS and COPD groups. The distributions of both EI and AT were compared between patients with ACOS and COPD. The variations between the pre- and post-BD measurements observed in patients with ACOS were compared with those in patients with COPD. A total of 71 patients completed the study, including 32 patients with COPD and 39 patients with ACOS. The patients with ACOS exhibited lower EI and more upper-zone-predominant EI distributions, compared with the patients with COPD. No significant differences were exhibited in AT and its distribution. Following bronchodilator administration, the variations in AT and expiratory MLD were greater in patients with ACOS than in patients with COPD. No differences were observed in the variations of EI and inspiratory MLD. Our results indicate that patients with ACOS have lower extent of emphysema and different emphysema distribution, as well as greater post-BD variations in air trapping, compared with patients with COPD. These findings suggest that CT densitometry characterizes ACOS as a distinct phenotype from COPD.

Entities:  

Keywords:  X-ray computed; airtrapping; emphysema; quantitative research; tomography

Mesh:

Year:  2016        PMID: 26742511     DOI: 10.3109/15412555.2015.1102874

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  8 in total

1.  Asthma-COPD Overlap Syndrome.

Authors:  Robert M Marron; Maria Elena Vega Sanchez
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04

2.  Sagittal-lung CT measurements in the evaluation of asthma-COPD overlap syndrome: a distinctive phenotype from COPD alone.

Authors:  Yanjuan Qu; Yiyuan Cao; Meiyan Liao; Zhiyan Lu
Journal:  Radiol Med       Date:  2017-03-03       Impact factor: 3.469

3.  Influence of Emphysema and Air Trapping Heterogeneity on Pulmonary Function in Patients with COPD.

Authors:  Kun Li; Yanli Gao; Zhenyu Pan; Xiuqin Jia; Yuchang Yan; Xiaohong Min; Kewu Huang; Tao Jiang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-12-06

Review 4.  Asthma-COPD Overlap Syndrome: What We Know and What We Don't.

Authors:  Don D Sin
Journal:  Tuberc Respir Dis (Seoul)       Date:  2016-12-30

5.  Heterogeneity of asthma-COPD overlap syndrome.

Authors:  Hyonsoo Joo; Deokjae Han; Jae Ha Lee; Chin Kook Rhee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-22

6.  Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.

Authors:  Mengshuang Xie; Wei Wang; Shuang Dou; Liwei Cui; Wei Xiao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-05-06

7.  Visual and Quantitative Assessments of Regional Xenon-Ventilation Using Dual-Energy CT in Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Comparison with Chronic Obstructive Pulmonary Disease.

Authors:  Hye Jeon Hwang; Sang Min Lee; Joon Beom Seo; Jae Seung Lee; Namkug Kim; Sei Won Lee; Yeon Mok Oh
Journal:  Korean J Radiol       Date:  2020-09       Impact factor: 3.500

8.  Current situation of asthma-COPD overlap in Chinese patients older than 40 years with airflow limitation: a multicenter, cross-sectional, non-interventional study.

Authors:  Jian Kang; Jinping Zheng; Baiqiang Cai; Fuqiang Wen; Wanzhen Yao; Xiaoju Zhang; Yan Chen; Guansong Wang; Wen Li; Jie Cao
Journal:  Ther Adv Respir Dis       Date:  2020 Jan-Dec       Impact factor: 4.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.